Research review
Chaga mushroom benefits: what the research does and doesn't show
No human trial of chaga mushroom supports a benefit at any dose. The evidence is cell and animal work, plus two case reports of kidney damage from large intakes. Here is what each study did, what it can't show, and where mycelium differs.
No human trial shows that chaga mushroom is good for you at any dose. A PubMed search on 2 October 2026 for Inonotus obliquus with the clinical-trial publication type returned no records. What exists is cell and animal work on extracts, and two case reports in which large intakes of chaga powder were followed by kidney damage.
What the evidence doesn't support
- Any benefit in people. We found no randomized or other trial of chaga in volunteers or patients, so there is no dose at which a benefit has been shown.
- Antioxidant effects from swallowing chaga. The best-known "human" study used human cells in a dish (below).
- Blood-sugar, liver, skin or immune effects. These come up in autocomplete and in marketing. Where research touches them, it is lab and animal work.
- Transfer from conk to mycelium. Most research and tea describe the hard black conk. A 2025 analysis found grain-fermented mycelium chaga products chemically very different from conk, so conk findings would not carry over to a mycelium capsule even if they were human findings.
What the trials found
There are no trials. Here is what exists instead, with what each can and cannot show.
Cells in a dish (2007). Researchers took white blood cells from 20 people with inflammatory bowel disease and 20 healthy volunteers, exposed them to hydrogen peroxide, and added a chaga ethanol extract at 10-500 micrograms per millilitre. Induced DNA damage fell by 54.9% in the patients' cells and 34.9% in the healthy cells. Nobody ingested anything, the material was an ethanol extract, and a result in a dish at a fixed challenge does not tell you what happens after a person swallows a capsule. Certainty for any benefit: very low.
A narrative review (2020). A review of Inonotus obliquus research summarised cell and animal findings on antioxidant activity, glucose and insulin sensitivity, immune effects and antiviral activity, mostly from extracts. Its own conclusion was that studies meeting evidence-based medicine criteria are needed. Its glucose findings come from lab and animal work and are not evidence that chaga changes blood sugar in people.
A platelet study in the lab and in mice (2006). An ethanol extract of chaga mycelia, and a peptide purified from it, reduced platelet aggregation in the lab, and the peptide did so in mice. No person took part. We cite it as a reason for caution about blood thinners, not as a benefit; see chaga mushroom and medications.
Two case reports of harm. A 69-year-old man who took 10-15 g a day of chaga powder plus 500 mg of vitamin C for about 3 months developed acute kidney injury; a biopsy showed calcium oxalate crystals, and his kidney function recovered about a month after treatment began. A 49-year-old man who took chaga powder for years, for a skin condition, reached end-stage kidney disease with oxalate deposits, and the leftover powder was assayed as extremely high in oxalate. A single case cannot say how common this is, and neither report establishes that a small dose of a mycelium powder carries the same risk. They are the only human outcomes we found, and they are not benefits. The man in the second report took chaga for his skin and still reached kidney failure; no benefit can be read from it.
A product analysis (2025). The lab analysis of chaga supplements is described above. Its authors are employed by a supplier of wildcrafted chaga, which is a stated conflict of interest, but the chemistry it reports is why we keep conk, extract and mycelium apart.
Questions people ask
What's chaga mushroom good for?
Nothing that a human trial has shown. It has a long folk history as a tea, and the modern research is lab and animal work. See the sections above.
What does chaga mushroom do for you?
We don't know. Without human trials the honest answer is that its effects in people are untested. The documented human outcomes are the two kidney case reports.
What is chaga mushroom powder or tea good for?
The same answer applies to powder, tea, tinctures and capsules: no human trial for any form. Tea and powder made from conk are also the forms in which oxalate has been assayed, in the 2020 case report.
Is chaga mushroom good for the liver?
We found no study showing that it is, and no liver-injury report either way. That is an absence of evidence, not a finding that it is safe or harmful.
Is chaga mushroom good for diabetes?
No human trial shows it. The review above describes glucose and insulin findings from cell and animal work. Anyone using glucose-lowering medication should read the interactions guide and talk to a doctor before taking chaga.
Is chaga mushroom good for the kidneys?
Nothing suggests it is. The documented kidney outcomes are the two harm reports above; see who should not take chaga mushroom.
Are chaga mushrooms good for dogs, skin or spiritual use?
We found no study of dogs or of skin use, and give no guidance; ask a veterinarian about a pet. Spiritual or ceremonial use is a matter of belief and outside what research can test.
Is chaga mushroom tea good for you?
No trial has tested it. If you drink it, the kidney reports above involved powder, so the oxalate point applies to any form made from the conk.
What is chaga mushroom used for?
Traditionally, as a folk tea; today, as powders, tinctures and capsules. See what is chaga mushroom for the forms.
When to talk to a doctor
Chaga mushroom is not a treatment for any condition, and nothing above supports using it as one. If you have kidney disease, a history of kidney stones, or take blood thinners or glucose-lowering medicine, talk to a doctor before taking any chaga product. If you are pregnant or nursing, we found no safety data, so ask a doctor first.
Sources
- Chaga mushroom extract inhibits oxidative DNA damage in lymphocytes of patients with inflammatory bowel disease In white blood cells from 20 patients and 20 healthy people, a chaga extract added to the dish reduced induced DNA damage; nobody swallowed any chaga.
- Inonotus obliquus - from folk medicine to clinical use A 2020 review of chaga research says the evidence is mostly cell and animal work and that properly designed human studies are still needed.
- Chaga mushroom-induced oxalate nephropathy that clinically manifested as nephrotic syndrome: A case report A 69-year-old man taking 10-15 g a day of chaga powder plus vitamin C for 3 months developed acute kidney injury with oxalate crystals; he recovered with treatment.
- Development of End Stage Renal Disease after Long-Term Ingestion of Chaga Mushroom: Case Report and Review of Literature A 49-year-old man who took chaga powder for years ended up with end-stage kidney disease and oxalate deposits; the leftover powder was very high in oxalate.
- Comparative Study of Chaga (Inonotus obliquus) Dietary Supplements Using Complementary Analytical Techniques Lab analysis of chaga supplements found grain-fermented mycelium products chemically very different from wild chaga conk, and starch-rich.
- Isolation and characterization of a novel platelet aggregation inhibitory peptide from the medicinal mushroom, Inonotus obliquus A lab and mouse study found a chaga mycelium extract and a peptide from it reduced platelet clumping; no person took part.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.